We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

115 hedge funds and large institutions have $74M invested in Sanofi Contingent Value Rights in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less funds holding

Funds holding: 118 → 115 (-3)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

19% less capital invested

Capital invested by funds: $91.5M → $74M (-$17.4M)

22% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 18

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
115
Holders Change
-3
Holders Change %
-2.54%
% of All Funds
3.07%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
7
Increased
14
Reduced
18
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EM
Elliott Management
New York
+$6.02M
2
OAM
Oxford Asset Management
United Kingdom
+$1.05M
3
CLOS
Compagnie Lombard Odier SCmA
Switzerland
+$699K
4
LCM
Lonestar Capital Management
California
+$365K
5
JP Morgan Chase
JP Morgan Chase
New York
+$34.8K

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$6.22M
2
WA
Whitebox Advisors
Minnesota
-$5.92M
3
PC
Pomelo Capital
New York
-$559K
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$260K
5
Millennium Management
Millennium Management
New York
-$163K
Name Holding Trade Value Shares
Change 		Change in
Stake
TL
26
TowerView LLC
New York
$268K – – –
CCA
27
Catalyst Capital Advisors
New York
$203K – – –
Goldman Sachs
28
Goldman Sachs
New York
$192K -$1.03K -1,471 -0.5%
DAM
29
Deltec Asset Management
New York
$167K -$699 -1,000 -0.4%
BCM
30
Basso Capital Management
Connecticut
$166K +$14K +20,000 +9%
FRM
31
Fore Research & Management
New York
$130K – – –
YCM
32
Yakira Capital Management
Connecticut
$112K – – –
First Eagle Investment Management
33
First Eagle Investment Management
New York
$99K – – –
ZIG
34
Zuckerman Investment Group
Illinois
$69K -$7 -10 -0%
EEG
35
E.E. Geduld
$68K – – –
PP
36
Paloma Partners
Connecticut
$68K – – –
UBS Group
37
UBS Group
Switzerland
$64K +$6.02K +8,613 +10%
Wells Fargo
38
Wells Fargo
California
$62K -$85 -122 -0.1%
TI
39
Telemetry Investments
New York
$58K -$52.7K -75,345 -47%
CAS
40
CTC Alternative Strategies
Illinois
$51.4K – – –
GI
41
GAMCO Investors
Connecticut
$50K -$73.4K -104,920 -58%
IRF
42
IBM Retirement Fund
New York
$47K – – –
ACA
43
Anchor Capital Advisors
Massachusetts
$41K – – –
KAM
44
Kazazian Asset Management
Florida
$39K -$23.5K -33,619 -37%
KAM
45
Knightsbridge Asset Management
California
$39K – – –
GCIA
46
Gabelli & Co Investment Advisers
New York
$36K – – –
OCM
47
Osterweis Capital Management
California
$34K -$61.7K -88,300 -64%
Korea Investment Corp
48
Korea Investment Corp
South Korea
$34K – – –
Commonwealth Equity Services
49
Commonwealth Equity Services
Massachusetts
$33K +$21 +30 +0.1%
Citadel Advisors
50
Citadel Advisors
Florida
$33K +$21.8K +31,214 +174%
1
2
3 4 5

GCVRZ Hedge Fund Activity: Q1 2015 in Review

115 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q1 2015, worth a combined $74M — down 19% from $91.5M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of GCVRZ and 7 opened new positions — a net loss of 1 holder — while 18 trimmed existing stakes and 14 added.

The largest buyer was Elliott Management, opening a new position worth an estimated $6.02M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $6.22M sold.

  • 115 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q1 2015, down from 118 in Q4 2014.
  • Funds reported $74M of Sanofi Contingent Value Rights stock for Q1 2015, down 19% quarter-over-quarter.
  • 7 funds opened new Sanofi Contingent Value Rights positions in Q1 2015 and 8 closed out, a net change of -1 holder.
  • The largest Sanofi Contingent Value Rights buyer in Q1 2015 was Elliott Management, an estimated $6.02M added.
  • The largest Sanofi Contingent Value Rights seller in Q1 2015 was Sphera Funds Management, an estimated $6.22M sold.

Based on aggregated 13F filings for Q1 2015.